DC
LLY icon

Dahring Cusmano’s Eli Lilly LLY Stock Holding History

Dahring Cusmano’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Hold
318
– – 0.18% 51
2025
Q4 		$342K Sell
318
-49
-13% -$46.9K 0.24% 40
2025
Q3 		$280K Buy
367
+5
+1% +$3.72K 0.2% 47
2025
Q2 		$282K Buy
362
+7
+2% +$5.44K 0.22% 44
2025
Q1 		$293K Buy
355
+5
+1% +$4.16K 0.25% 41
2024
Q4 		$270K Buy
+350
New +$290K 0.24% 46

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dahring Cusmano's LLY Position: Q1 2026 in Review

Dahring Cusmano held its Eli Lilly (LLY) position steady in Q1 2026 at 318 shares worth $293K. The position accounts for 0.18% of the portfolio, ranked #51.

Dahring Cusmano first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $342K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dahring Cusmano held 318 shares of Eli Lilly worth $293K as of Q1 2026.
  • Dahring Cusmano left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.18% of Dahring Cusmano's portfolio in Q1 2026, its #51 holding.
  • Dahring Cusmano first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Dahring Cusmano's Eli Lilly position peaked at $342K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dahring Cusmano's 13F filing for Q1 2026, filed 5 May 2026.